跳至主要内容
临床试验/NCT04699760
NCT04699760已完成4 期

Single-blinded, Randomized, Controlled Trial About the Effects of n-3 LCPUFAs on Weight and Functional Status in Patients With Colorectal Cancer.

University of Copenhagen2 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2015年4月最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
入组人数
50
试验地点
2
主要终点
Weight loss

研究概览

简要总结

The aim of this study is to determine the effects of n-3 PUFAs on weight, physical funktion and quality of life in patients with colorectal cancer.

详细描述

Primary outcomes:

  • Weight
  • Physical function
  • Hand-grip strength

Secondary outcomes:

  • Quality of life
  • Mid-upperarm circumference
  • Incorporation of n-3 PUFAs into cell membranes

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • ≥18 years
  • Patients with diagnosed colorectal cancer with metastases treated with chemotherapy on Rigshospitalet, Copenhagen

排除标准

  • < 18 years
  • Patients in palliative care
  • patients with haemophilia
  • Patiens in treatment of anti-coagulation
  • Patients with genetic hyperkolesterolemia
  • Pre-dialytic patients (GFR<15ml/min/1,73m2 eller kreatinin ≥500 mmol/L)

结局指标

主要结局

Weight loss

时间窗: 8 weeks

Difference in weight (kg) from inclusion to 8 week status

次要结局

  • Performance status - common daily abilities(8 weeks)
  • quality of Life score(8 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Jens Rikardt Andersen

Associate Professor

University of Copenhagen

研究点 (2)

Loading locations...

相似试验